Story preview
Topics in this story
Continue reading on the publisher site for the full article.
Read on publisher →The Pharma Letter
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
3
in the last 3 days
First reported
2 days ago
2 outlets since
Countries
2 other outlets reported this story in the last 3 days.
Context from Wikipedia on the organisations, people and places in this story.
Genetically engineered T cell
Chimeric antigen receptor T cells —also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors—are receptor proteins that have been engineered to give T cells the new ability to target a specific antigen. The receptors are chimeric in that they combine both antigen-binding and T cell activating functions into a single receptor.
More on Wikipedia ↗